Physicochemical and Structural Properties Regulating Placental Drug Transfer

Fetal and Neonatal Physiology: Third Edition

Volumn 1-2, Issue , 2003, Pages 197-211

  Plonait, Sabine Luise ^a   Nau, Heinz ^b  

^a University of Hannover ^*  (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35649020715     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50024-2     Document Type: Chapter

References (217)

1. Luke B Maternal-fetal nutrition. Clin Obstet Gynecol 1994, 37:93.
2. Chauoi R, Bollmann R The indirect transplacental therapy of the fetus. Geburtshilfe Frauenheilkd 1995, 55:99.
3. Ward RM Pharmacological treatment of the fetus. Clin Pharmacokinet 1995, 28:343.
4. Pacifici GM, Nottoli R Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995, 28:235.
5. Yerby MS Pregnancy, teratogenesis, and epilepsy. Neurol Clin 1994, 12:749.
6. Kacew S Effect of over-the-counter drugs on the unborn child: what is known and how should this influence prescribing?. Paediatr Drugs 1999, 1:75.
7. Jacqz-Aigrain E Placental transfer and fetal risks. Paediat Perinat Drug Ther 1999, 3:36.
8. Schwarzt S Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development. Arch Toxicol 2001, 75:381.
9. Jauniaux E, Gulbis B In vivo investigation of placental transfer early in human pregnancy. Eur J Obstet Gynecol Reprod Biol 2000, 92:45.
10. Ostrea EM, et al. The detection of heroin, cocaine, and cannaboid metabolites in meconium of infants of drug-dependent mothers. Ann NY Acad Sci 1989, 562:373.
11. Ostrea EM, et al. A new method for the rapid isolation and detection of drugs in the stools (meconium) of drug dependent infants. Ann NY Acad Sci 1989, 562:372.
12. Nau H Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect 1986, 70:113.
13. Garbis-Berkvens JM, Peters PWJ Comparative morphology and physiology of embryonic and fetal membranes. Pharmacokinetics in Teratogenesis 1987, Vol 1:13-44. CRC Press, Boca Raton, FL. H. Nau, W.J. Scott (Eds.).
14. Heap RB Placenta structure and function. J Reprod Fertil 1982, 31(Suppl):1.
15. Ramsey EM The Placenta: Human and Animal 1982, Praeger, New York.
16. DeSesso JM Anatomical and developmental aspects of the maternal-embryonal/fetal interface. Teratology 2000, 61:468.
17. Ruehl R, et al. Effects of all-trans-retinoic acid an all-trans-retinoyl glucuronide in two in vitro systems of distinct biological complexity. Arch Toxicol 2001, 75:497.
18. Hartvig M, et al. Positron emission tomographic studies on placenta transfer and in teratology. Teratology 1998, 58:20A.
19. Bourget P, et al. Models for placental transfer studies of drugs. Clin Pharmacokinet 1995, 28:161.
20. Mirkin BL, Singh S Placental transfer of pharmacologically active molecules. Perinatal Pharmacology and Therapeutics 1976, 1-69. Academic Press, New York. B.L. Mirkin (Ed.).
21. Miller RK, et al. The transport of molecules across placenta membranes. The Cell Surface in Animal Embryogenesis and Development 1976, 145-223. Elsevier North Holland Biomedical Press, Amsterdam. G. Poste, G.L. Nicolson (Eds.).
22. Nau H, Liddiard C Placental transfer of drugs during early human pregnancy. Role of Pharmacokinetics in Prenatal and Perinatal Toxicology 1978, 465-481. Georg Thieme, Stuttgart. D. Neubert (Ed.).
23. Green TP, et al. Determinants of drug disposition and effect in the fetus. Annu Rev Pharmacol Toxicol 1979, 19:285.
24. Waddel WJ, Marlowe C Biochemical regulation of the accessibility of teratogens to the developing embryo. The Biochemical Basis of Chemical Teratogenesis 1981, 1-62. Elsevier, New York. M.R. Juchau (Ed.).
25. Dencker L, Danielsson BRG Transfer of drugs to the embryo and fetus after placentation. Pharmacokinetics in Teratogenesis 1987, Vol 1:55-69. CRC Press, Boca Raton, FL. H. Nau, W.J. Scott (Eds.).
26. Nau H, Mirkin BL Fetal and maternal clinical pharmacology. Drug Treatment: Principles and Practice of Clinical Pharmacology 1982, 79-117. Adis Press, Sydney. 3rd ed. G.S. Avery (Ed.).
27. Thornburg KL, Faber JJ Transfer of hydrophilic molecules by placenta and yolk sac of the guinea pig. Am J Physiol 1977, 2:C111.
28. Bassily M, et al. Determinants of placental drug transfer: studies in the perfused human placenta. J Pharm Sci 1995, 84:1054.
29. Waddell WJ, Marlowe C Transfer of drugs across the placenta. Pharmacol Ther 1981, 14:375.
30. Krauer B, Drauer F, Hytten FE Drug disposition and pharmacokinetics in the maternal placental fetal unit. Pharmacol Ther 1980, 10:301.
31. Schoondermark Van-de-Ven E, et al. Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus. Antimicrob Agents Chemother 1994, 38:1922.
32. Slikker W, Miller RK Placental metabolism and transfer. Role in developmental toxicology. Developmental Toxicology 1994, 245. Raven Press, New York. 2nd ed. C.A. Kimmel, J. Buelke-Sam (Eds.).
33. Maickel RP, Snodgrass WR Physicochemical factors in maternal-fetal distribution of drugs. Toxicol Appl Pharmacol 1973, 26:218.
34. Sanchez-Alcaraz A, et al. Placental transfer and neonatal effects of propofol in caesarean section. J Clin Pharm Ther 1998, 23:19.
35. 14C)methyl-parathion in rats. Toxicol Sci 2000, 53:5.
36. Takahashi O, Oish S Disposition of orally administered bisphenol A in pregnancy rats and the placental transfer to fetuses. J Toxicol Sci 1999, 24:297.
37. Schenker S, et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther 1993, 53:329.
38. Simone C, et al. Transfer of cocaethylene across the human term placenta. FASEB J 1995, 9:A693.
39. Pastrakuljic A, et al. Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. Placenta 1999, 20:499.
40. Krause W, Mechelke B Placental transfer of the anxiolytic β-carboline abecarnil in rabbit. Arzneimittelforschung 1992, 42:1079.
41. Giroux M, et al. Influence of maternal blood flow on the placental transfer of three opioids-fentanyl, alfentanil, sufentanil. Biol Neonate 1997, 72:133.
42. Nanovskaya T, et al. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002, 300:26.
43. Fortunato SJ, et al. Transfer of ceftizoxime surpasses that of cefoperazone by the isolated human placenta perfused in vitro. Obstet Gynecol 1990, 75:830.
44. Fortunato SJ, et al. Transfer of Timentin (ticarcillin and clavulanic acid) across the in vitro perfused human placenta: comparison with other agents. Am J Obstet Gynecol 1992, 167:1595.
45. Liebes L, et al. Transfer of zidovudine (AZT) by human placenta. J Infect Dis 1990, 161:203.
46. Patterson TA, et al. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Drug Metab Dispos 1997, 25:453.
47. Boal JH, et al. Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours. Toxicol Appl Pharmacol 1997, 143:13.
48. Pereira CM, et al. Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques. Antimicrob Agents Chemother 1994, 38:781.
49. Bawdon RE, et al. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta. Am J Obstet Gynecol 1992, 167:1570.
50. Pons JC, et al. Placental passage of azidothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Eur J Obstet Gynaecol Reprod Biol 1991, 40:229.
51. Watts DH, et al. Pharmacokinetic disposition of zidovudine during pregnancy. J Infect Dis 1991, 163:226.
52. Liebes L, et al. Further observations on zidovudine transfer and metabolism by human placenta. AIDS 1993, 7:590.
53. Tuntland T, et al. In vitro models to predict the in vivo mechanism, rate and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am J Obstet Gynecol 1999, 180:198.
54. Frenkel LM, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991, 164:569.
55. Nau H, Bass R Transfer of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to the mouse embryo and fetus. Toxicology 1981, 20:299.
56. Bourget P, et al. Transplacental passage of cyclosporine after liver transplantation. Transplantation 1990, 49:663.
57. Nau H, et al. Transfer of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via placenta and milk, and postnatal toxicity in the mouse. Arch Toxicol 1986, 59:36.
58. 1 in preterm pregnancy. Obstet Gynecol 1990, 75:334.
59. Staud F, et al. Pharmacokinetic examination of p-aminobenzoic acid passage through the placenta and the small intestine in rats. J Drug Target 1997, 5:57.
60. 14C-dimethyltubocurarine. Br J Anaesth 1972, 44:557.
61. 14C-dimethyltubocurarine during caesarean section. Br J Anaesth 1976, 48:239.
62. Booth PN, et al. Pancuronium and the placental barrier. Anaesthesia 1977, 32:320.
63. Abouleish E, et al. Pancuronium in caesarean section and its placental transfer. Br J Anaesth 1980, 52:531.
64. Demetriou M, et al. Placental transfer of ORG NC54 in women undergoing caesarean section. Br J Anaesth 1982, 54:643.
65. Nöschel H, et al. Plazentapassage von Natriumsalizylat. Zentralbl Gynakol 1972, 94:437.
66. Tagashira E, et al. Correlation of teratogenicity of aspirin to the stage specific distribution of salicylic acid in rats. Jpn J Pharmacol 1981, 31:563.
67. Nau H, et al. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981, 219:768.
68. Kaneko S, et al. Transplacental passage and half-life of sodium valproate in infants born to epileptic mothers. Br J Clin Pharmacol 1983, 15:503.
69. Nau H, et al. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites. J Pediatr 1984, 104:627.
70. i in the embryo during organogenesis and structure-activity considerations. Arch Toxicol 1987, 11:128.
71. Hendrickx AG, et al. Valproic acid developmental toxicity and pharmacokinetics in the rhesus-monkey: an interspecies comparison. Teratology 1988, 38:329.
72. Binkerd PE, et al. Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam Appl Toxicol 1988, 11:485.
73. Fowler DW, et al. Transplacental transfer and biotransformation studies of valproic acid and its glucuronide(s) in the perfused human placenta. J Pharmacol Exp Ther 1989, 24:318.
74. Tzimas G, et al. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid. Arch Toxicol 1994, 68:119.
75. Worsaschk HJ, et al. Zur diaplazentaren Passage von 1-Askobrinsäure. Zentralbl Gynakol 1974, 96:910.
76. Greenberg RA, et al. Measuring the exposure of infants to tobacco smoke: nicotine and cotinine in urine and saliva. N Engl J Med 1984, 310:1075.
77. Luck W, et al. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985, 8:384.
78. 3H]LSD in the reproductive system of the male rat and placental transfer in the female rat. Experientia 1977, 15:501.
79. Li PJ, et al. Transfer of lead via placenta and breast milk in human. Biomed Environ Sci 2000, 13:85.
80. Yang J, et al. Maternal-fetal transfer of metallic mercury via the placenta and milk. Ann Clin Lab Sci 1997, 27:135.
81. Carson RJ, Reynolds F Elimination of bupivacaine and pethidine from the rabbit feto-placental unit. Br J Anaesth 1992, 69:150.
82. Nau H Clinical pharmacokinetics in pregnancy and perinatology. Dev Pharmacol Ther 1985, 8:149.
83. Johnson RF, et al. A comparison of the placental transfer of ropivacaine versus bupivacaine. Anesth Analg 1999, 89:703.
84. Biehl D, et al. Placental transfer of lidocaine. Anesthesiology 1978, 48:409.
85. Brown WU, et al. Acidosis, local anesthetics and the newborn. Obstet Gynecol 1976, 48:27.
86. Morishima HO, Cavino BTG Toxicity and distribution of lidocaine in nonasphyxiated and asphyxiated baboon fetuses. Anesthesiology 1981, 54:182.
87. Datta S, et al. Epidural anesthesia for cesarean section in diabetic parturients: maternal and neonatal acid-base status and bupivacaine concentration. Anesth Analg 1981, 60:574.
88. Denson DD, et al. Bupivacaine protein binding in the term parturient: effects of lactic acidosis. Clin Pharmacol Ther 1984, 35:702.
89. Kennedy RL, et al. Effects of changes in maternal-fetal pH on the transplacental equilibrium of bupivacaine. Anesthesiology 1979, 51:50.
90. Froescher W, et al. Protein binding of valproic acid in maternal and umbilical cord serum. Epilepsia 1984, 25:244.
91. Varma DR Modification of transplacental distribution of salicylate in rats by acidosis and alkalosis. Br J Pharmacol 1988, 93:978.
92. Jacobson RL, et al. Transfer of aspirin across the perfused humasn placental cotyledon. Am J Obstet Gynecol 1991, 164:290.
93. Nau H, Scott WJ Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo. Nature 1986, 323:276.
94. i) in primate embryos by transplacental distribution of DMO (5,5' dimethyloxazolidine-2,4 dione). Teratology 1988, 37:479.
95. Keberle H, et al. Biochemical effects of drugs in the mammalian conceptus. Ann NY Acad Sci 1965, 123:253.
96. Nau H, et al. Pharmacokinetic and chiral aspects of thalidomide and EM12 teratogenesis in monkey and rat. Non Human Primates: Developmental Biology and Toxicology 1988, 461-476. Überreuter, Vienna. D. Neubert (Ed.).
97. Schmahl HJ, et al. The enantiomers of the teratogenic thalidomide analogue EM 12. I. Chiral inversion and plasma pharmacokinetics in the marmoset monkey. Arch Toxicol 1988, 62:200.
98. Ushigome F, et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of p-glycoprotein. Eur J Pharmacol 2000, 408:1.
99. Pavek P, et al. Influence of P-glycoprotein on the transplacental passage of cyclosporin. J Pharm Sci 2001, 90:1583.
100. Ito S Transplacental treatment of fetal tachycardia: implication of drug transporting proteins in the placenta. Semin Perinatol 2001, 25:196.
101. Magee KP, et al. Ex vivo human placental transfer of rifampin and rifabutin. Infect Dis Obstet Gynecol 1996, 4:319.
102. Wise T, et al. The influence of protein binding upon tissue fluid levels of six beta-lactams. J Infect Dis 1980, 142:77.
103. Mortimer RH, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997 1997, 82:3099.
104. Brown CEL, et al. Placental transfer of cefazolin and piperacillin in pregnancies remote from term complicated by Rh isoimmunization. Am J Obstet Gynecol 1990, 163:938.
105. Tsadkin M, et al. Albumin-dependent digoxin transfer in isolated perfused human placenta. Int J Pharmacol Ther 2001, 39:158.
106. Kanhai HHH, et al. Transplacental passage of digoxin in severe rhesus immunization. J Perinat Med 1990, 18:339.
107. Schenker S, et al. Olanzapine transfer by human placenta. Clin Exp Pharmacol Physiol 1999, 26:691.
108. Kurz H, et al. Differences in the binding of drugs to plasma proteins from newborn and adult man. I. Eur J Clin Pharmacol 1977, 11:463.
109. Kurz H, et al. Differences in the binding of drugs to plasma proteins from newborn and adult man. II. Eur J Clin Pharmacol 1977, 11:469.
110. Lovecchio JL, et al. Serum protein binding of salicylate during pregnancy and the puerperium. Dev Pharmacol Ther 1981, 2:172.
111. Hill MD, Abramson FP The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clin Pharmacokinet 1988, 14:156.
112. 1-acid glyco-protein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol 1984, 91:875.
113. Nau H, Krauer B Serum protein binding of valproic acid in fetus-mother pairs throughout pregnancy: correlation with oxytocin administration and albumin and free fatty acid concentrations. J Clin Pharmacol 1986, 26:215.
114. Krauer B, et al. Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy. Br J Obstet Gynaecol 1986, 93:322.
115. Dean M, et al. Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther 1980, 28:253.
116. Kuhnz W, Nau H Differences in in vitro binding of diazepam and N-desmethyldiazepam to maternal and fetal plasma proteins at birth: relation to free fatty acid concentration and other parameters. Clin Pharmacol Ther 1983, 34:220.
117. Ridd MJ, et al. Differential transplacental binding of diazepam: causes and implications. Eur J Clin Pharmacol 1983, 24:595.
118. Nau H, et al. Serum protein binding of desmethyldiazepam, furosemide, indomethacin, warfarin, and phenobarbital in human fetus, mother, and newborn infants. Pediatr Pharmacol 1983, 3:219.
119. Wegener S, et al. Salicylate protein binding in the serum of the neonate during the first postnatal week: comparison with maternal and fetal binding at birth. IRCS J Med Sci 1984, 12:685.
120. Hamar C, Levy G Serum protein binding of drugs and bilirubin in newborn infants and their mothers. Clin Pharmacol Ther 1980, 28:58.
121. Hamar C, Levy G Factors affecting the serum protein binding of salicylic acid in newborn infants and their mothers. Pediatr Pharmacol 1980, 1:31.
122. Nau H, et al. Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week related to increased free fatty acid levels. Br J Clin Pharmacol 1984, 17:92.
123. Elphick MC, et al. Concentrations of free fatty acids in maternal and umbilical cord blood during elective caesarean section. Br J Obstet Gynaecol 1976, 83:539.
124. Ogburn PL, et al. Levels of free fatty acids and arachidonic acid in pregnancy and labor. J Lab Clin Med 1980, 95:943.
125. Itami T, Kanoh S A possible mechanism for the potentiation of the fetal toxicities of salicylates by bacterial pyrogen. Pharmacokinetics in Teratogenesis 1987, Vol 2:27-39. CRC Press, Boca Raton, FL. H. Nau, W.J. Scott (Eds.).
126. Jäger-Roman E, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986, 108:997.
127. Gonzales de Dios, et al. "Floppy infant" syndrome in twins secondary to the use of benzodiazepines during pregnancy. Rev Neurol 1999, 29:121.
128. Gillberg C "Floppy infant syndrome" and maternal diazepam. Lancet 1977, 1:244.
129. Rementeria JL, Bhatt K Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 1977, 90:123.
130. Speight ANP Floppy infant syndrome and maternal diazepam and/or nitrazepam. Lancet 1977, 2:878.
131. Kuhnz W, et al. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behavior. Dev Pharmacol Ther 1988, 11:147.
132. Prybys KM Life-threatening superwarfarin ingestion in a second trimester pregnancy. J Toxicol Clin Toxicol 1997, 34:567.
133. Reisenberger K, et al. Transfer of erythropoietin across the placenta perfused in vitro. Obstet Gynecol 1997, 89:738.
134. Koren G Glyburide and fetal safety: transplacental pharmacokinetic considerations. Reprod Toxicol 2001, 15:227.
135. Elliott BD, et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994, 171:653.
136. Jauniaux E, et al. In-vivo study of diazepam transfer across the first trimenon human placenta. Hum Reprod 1996, 11:889.
137. Siu SS, et al. A study on placental transfer of diclofenac in the first trimester of human pregnancy. Hum Reprod 2000, 15:2423.
138. Simone C, et al. Transfer of heparin across the human term placenta. Clin Invest Med 1995, 18:B18.
139. Saivin S, et al. Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model. Eur J Obstet Reprod Biol 1991, 42:221.
140. Schneider D, et al. Placental transfer of low-molecular weight heparin. Geburtshilfe Frauenheilkd 1995, 55:93.
141. Dawes J, Lumbers ER Low molecular weight dermatan sulphate (Desmin 370) does not cross the ovine placenta. Br J Haematol 1993, 84:90.
142. Schneider H, et al. Transfer of amino acids across the in vitro perfused human placenta. Pediatr Res 1979, 13:236.
143. Schneider H, et al. Transfer of glutamic acid across the human placenta perfused in vitro. Br J Obstet Gynaecol 1979, 86:299.
144. Karl PI, Fisher SE Taurine transport by microvillous membrane vesicles and the perfused cotyledon of the human placenta. Am J Physiol 1990, 258:C443.
145. Dancis J, et al. Transfer of riboflavin by the perfused human. Pediatr Res 1985, 19:1143.
146. Carrol MJ, et al. The relationship between placental protein synthesis and transfer of amino acids. Biochem J 1983, 210:99.
147. Kihlstrom I, Kihlstrom JE An improved technique for perfusion of the guniea pig placenta in situ giving viable conditions demonstrated by placental transport of amino-acids (L- and d-alanine). Biol Neonate 1981, 39:150.
148. Challier JC, et al. Passage of S(+) and R(-) γ-vinyl-GABA across the human isolated perfused placenta. Br J Clin Pharmacol 1992, 34:139.
149. Lagrange F, et al. Passage of S-(+)- and R-(-)-ketotifen across the human isolated perfused placenta. Fundam Clin Pharmacol 1998, 12:286.
150. Tran A, et al. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers. Br J Clin Pharmacol 1998, 45:409.
151. Capece BP, et al. Placental transfer of albendazole sulphoxide enantiomers in sheep. Vet J 2002, 163:155.
152. Nau H Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol 2001, 45:S183.
153. Soprano DR, et al. Retinol-binding protein synthesis and secretion by the rat visceral yolk sac. J Biol Chem 1988, 263:2934.
154. Creech Kraft J, et al. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer. Toxicol Appl Pharmacol 1987, 87:474.
155. Kochhar DM, et al. Teratogenicity and disposition of various retinoids in vivo and in vitro. Pharmacokinetics in Teratogenesis 1987, Vol 2:173-186. CRC Press, Boca Raton, FL. H. Nau, W.J. Scott (Eds.).
156. Reiners J, et al. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice. Reprod Toxicol 1988, 2:19.
157. Nau H, et al. Teratogenesis of retinoids: aspects of species differences and transplacental pharmacokinetics. Approaches to Elucidate Mechanisms in Teratogenesis 1986, 1-15. Hemisphere, Washington, DC. F. Welsch (Ed.).
158. Eckhoff C, et al. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits. Toxicol Appl Pharmacol 1994, 125:34.
159. Tzimas G, et al. Developmental stage-associated differences in the transplacental distribution of 13-cis and all-trans-retinoic acid as well as their glucuronides in rats and mice. Toxicol Appl Pharmacol 1995, 113:91.
160. Nau H Chemical structure-teratogenicity relationship in risk assessment of developmental toxicants. Hum Exp Toxicol 1995, 14:683.
161. Collins MD, et al. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats. Toxicol Appl Pharmacol 1994, 127:132.
162. Hummler H, et al. Maternal pharmacokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey. Teratology 1994, 50:184.
163. Tomson T, Villeán T Ethosuximide enantiomers in pregnancy and lactation. Ther Drug Monit 1994, 16:621.
164. 12. Trophoblast Res 1983, 1:121.
165. Henderson GI, et al. Folate transport by the human placenta: normal transport and role of short-term exposure to ethanol. Placenta 1991, 12:397.
166. Holm J, et al. Characterization of the folate receptor in human molar placenta. Biosci Rep 1996, 16:379.
167. Bawdon RE, et al. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term placenta. Am J Obstet Gynecol 1992, 167:1570.
168. Liebes L, et al. Further observations on zidovudine transfer and metabolism by human placenta. AIDS 1993, 7:590.
169. Poms JC, et al. Placental passage of azidothymidine (AZT) during the second trimester of pregnancy: study by direct fetal sampling under ultrasound. Eur J Obstet Gynaecol Reprod Biol 1999, 40:229.
170. Gilstrap LC, et al. The transfer of the nucleoside analog ganciclovir across the perfused human placenta. Am J Obstet Gynecol 1994, 170:967.
171. Henderson GI, et al. Acyclovir transport by the human placenta. J Lab Clin Med 1992, 120:885.
172. Varma DR Investigation of the maternal to foetal serum concentration gradient of dexamethasone in the rat. Br J Pharmacol 1986, 88:815.
173. Montano MM, et al. Sex differences in plasma corticosterone in mouse fetuses are mediated by differential placental transport from the mother and eliminated by maternal adrenalectomy or stress. J Reprod Fertil 1993, 99:283.
174. Funkhouser JD, et al. Distribution of dexamethasone between mother and fetus after maternal administration. Pediatr Res 1978, 12:1053.
175. Petersen MC, et al. The placental transfer of betamethasone. Eur J Clin Pharmacol 1980, 18:245.
176. McNay JL, Dayton PG Placental transfer of a substituted pteridine from fetus to mother. Science 1970, 167:988.
177. Nakayama S, et al. Pharmacokinetic study on calcitriol injectable in rats. III. Transfer into the fetus and milk in rats after single intravenous administration. Yakuri Chiro 1995, 23:315.
178. Miller RK, et al. Diethylstilbestrol: placental transfer, metabolism, covalent binding and fetal distribution in the Wistar rat. J Pharmacol Exp Ther 1981, 220:358.
179. Slikker W, et al. Comparison of the transplacental pharmacokinetics of 17β-estradiol and diethylstilbestrol in the subhuman primate. J Pharmacol Exp Ther 1978, 221:173.
180. Slikker W Disposition of selected naturally occurring and synthetic steroids in the pregnant rhesus monkey. Pharmacokinetics in Teratogenesis 1987, Vol 1:149-176. CRC Press, Boca Raton, FL. H. Nau, W.J. Scott (Eds.).
181. Degen GH, et al. Transplacental transfer of the phytoestrogen daizein in DA/Han rats. Arch Toxicol 2002, 76:23.
182. Huch R, Huch A Erythropoietin in obstetrics. Hematol Oncol Clin North Am 1994, 8:1021.
183. Valenzuela GJ, et al. Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late-gestational pregnant sheep. Am J Obstet Gynecol 1993, 169:897.
184. Valenzuela GJ, et al. Newborn oxytocin antagonist (atosibam) levels during maternal infusion. Am J Obstet Gynecol 1993, 169:374.
185. Waysbort A, et al. Experimental study of transplacental passage of alpha interferon by two assay techniques. Antimicrob Agents Chemother 1993, 37:1232.
186. Simone C, et al. Protein C transfer and secretion by the human term placenta perfused in vitro. Clin Invest Med 1995, 18:B16.
187. Bauman WA, Yalow RS Transplacental passage of insulin complexed to antibody. Proc Natl Acad Sci USA 1981, 78:4588.
188. Menon RK, et al. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. N Engl J Med 1990, 323:309.
189. Masters CL, et al. Plasma protein metabolism and transfer to the fetus during pregnancy in the rat. Am J Physiol 1969, 216:876.
190. Gitlin JD, Gitlin D Protein binding by specific receptors on human placenta, murine placenta, and suckling murine intestine in relation to protein transport across these tissues. J Clin Invest 1974, 54:1155.
191. Balfour AH, Jones EA The binding of plasma proteins to human placental cell membranes. Clin Sci Mol Med 1977, 52:383.
192. Brambell FWR The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet 1966, 2:1087.
193. Vahlquist A, Nilsson S Vitamin A transfer to the fetus and to the amniotic fluid in rhesus monkey (Macaca mulatta). Ann Nutr Metab 1984, 28:321.
194. Takahashi YI, et al. Vitamin A and retinol-binding protein metabolism during fetal development in the rat. Am J Physiol 1977, 233:E263.
195. Soprano DR, et al. Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development in the rat. Proc Natl Acad Sci USA 1986, 83:7330.
196. Strelling MK Transfer of folate to the fetus. Dev Med Child Neurol 1976, 18:533.
197. Dumaswala R, et al. An anion exchanger mediates bile acid transport across the placental microvillous membrane. Am J Physiol 1993, 264:G1016.
198. Itoh S, et al. Foetal maternal relationship of bile acid pattern estimated by high-pressure liquid chromatography. Biochem J 1982, 204:1411.
199. Khedun SM, et al. Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?. Paediatr Drugs 2000, 2:419.
200. Elliott BD, et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991, 165:807.
201. Pascual MJ, et al. Enhanced efficiency of the placental barrier to cisplatin through binding to glycolic acid. Anticancer Res 2001, 21:2703.
202. Barzago MM, et al. Placental transfer of valproic acid after liosome encapsulation during in vitro human placenta perfusion. J Pharmacol Exp Ther 1996, 277:79.
203. Fortunato SJ, et al. Placental transfer of cefoperazone and sulfbactam in the isolated in vitro perfused human placenta. Am J Obstet Gynecol 1988, 159:1002.
204. Maberry MC, et al. Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis. Gynecol Obstet Invest 1992, 33:185.
205. Heikkilä A, Erkkola R Review of β-lactam antibiotics in pregnancy. Clin Pharmacokinet 1994, 27:49.
206. Heikkilä A, et al. The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women. Br J Clin Pharmacol 1992, 33:629.
207. Heikkilä A, et al. Pharmacokinetics and transplacental passage of imipenem during pregnancy. Antimicrob Agents Chemother 1992, 36:2652.
208. Leeuw JW, et al. Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes. Obstet Gynecol 1993, 81:255.
209. Fernandez H, et al. Fetal levels of tobramycin following maternal administration. Obstet Gynecol 1990, 76:992.
210. Mattie H Clinical pharmacokinetics of aztreonam. Clin Pharmacokinet 1994, 26:99.
211. Fernandez H, et al. Fetal levels of tobramycin following maternal administration. Obstet Gynecol 1990, 76:992.
212. Gilstrap LC, et al. Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis. Obstet Gynecol 1988, 72:124.
213. Heikkinen T, et al. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. Br J Obstet Gynaecol 2000, 197:770.
214. Johnson D, et al. N-acetylcysteine does not cross the human term placenta. FASEB J 1995, 9:A693.
215. Horowitz RS, et al. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol 1997, 35:447.
216. Szefalusi Z, et al. Direct evidence for placental allergen transfer. Pediatr Res 2000, 48:404.
217. Little BB, VanBeveren Placental transfer of selected substances of abuse. Semin Perinatol 1996, 20:147.